Cancer Center Support Grant Site Review Date
description
Transcript of Cancer Center Support Grant Site Review Date
Cancer Center Support Grant Site ReviewDate
Cancer Center Support Grant Site ReviewDate
Signals, Pathways and Targets
Program Leaders: John Lowengrub, Ph.D.
Marian L. Waterman, Ph.D.2011 Chao Family Cancer Center Retreat
Palm Springs
Rationale
• Cancer is a complex adaptive system with dynamic regulatory pathways (Dev Biol, Cell Biol, Biochem)
• Modeling dynamic interactions is critical for understanding progression and response to treatment (Systems Biol)
• The SPT program reflects this multi-disciplinary approach to cancer
Systems, Pathways and Target Program: 56 members
The SPT ProgramCancer Relevant SPT Publications, 1/2011 – 9/2011
Total for Program SPT(Cancer Projects)
NCI
Other NIH
ACS
NSF
Other Peer Reviewed
Industry Non-Peer Reviewed
Other Non-Peer Reviewed
$17,134,815 Total Annual Direct Costs (peer reviewed)
$2,695,977 (NCI)
Signals, Pathways and Targets: Program Metrics
Systems, Pathways and Targets Program ThemesSystems Organ Pathway Target
Baldi (Blumberg) Anderson (Bardwell)
Bardwell Calof Arora (Edinger)
(Calof) Donovan Blumberg (Fruman)
Frank (Hoang) Casali Kaiser
(Komarova) (Krowleski) Chan Komarova
Lander (Lander) Cho (Steele)
Nie (Lee, E) Dai (Thompson)
Thornton Limoli Edinger (Walsh)
Wan (Lowengrub) Fan (Waterman)
(Wodarz) (Nie) Fruman Wodarz
(Zlotnik) Schilling Hoang (Zlotnik)
Steele Huang, L
(Wan) Huang, T
(Zhou) Kaiser
Krolewski
(Lander)
Lee, E
Levin
Lilly
(Nie)
Sandmeyer
Sassone-Corsi
(Schilling)
Thompson
(Want)
Walsh
Warrior
Waterman
Yokomori
Zlotnik
Program Co-Leader: John Lowengrub
•Angiogenesis•Macrophages•Fibroblasts•Immune cells
NIH GO Grant. PIs: Lander, Lowengrub
13 National Centers for Systems Biology (NIH P50)PI: Lander (SPT)Other key personnel: SPT: Calof, Bardwell, Nie, WanOIB: Gratton
http://www.systemscenters.org/
Renewal (2011):Theme B (Calof): Control of Growth
and MorphogenesisSPT: Edwards, Lander, Lowengrub,
Nie, Waterman
Intestinal organoids
New research initiative•Cellular cross-talk in the human colon cancer microenvironmentNIH/PPG: Expected submission: May 2012PI: Hughes (ABT); Project leaders: Waterman (SPT), Hughes (ABT), George (ABT), Lowengrub (SPT); Core directors: Hughes, Edwards (SPT), Hui
Waterman Hughes
George Lowengrub
Komarova Wodarz
Systems Modeling
Bench to Bedside: Krolewski, Fruehauf, Lilly, Dash
Prostate Disease Oriented Team (DOT) Clinical Trials Open for Accrual: 11Trials developed directly from DOT activities: 3 (UCI-10-11; UCI-10-41; UCI-
11-02)
cMetNeuropilin
Dr. Bang HoangWnt Signaling in Sarcomas
Wnt Signaling and Metastasisin OsteosarcomaWIF-1, Frzb
Druggable Wnt Target Genesc-METNeuropilin
2011 Kappa Delta Ann Doher Vaughn Award
Career Development Award: 2011 - 2014
NIH K08 CA11600
Dr. Bang HoangWnt Signaling in Sarcomas
PP242INK128
Bench to Bedside: Dr. David Fruman
Dr. David Fruman
Next-Gen mTOR inhibitors
A New Target: Dr. Aimee Edinger
PI: Aimee Edinger (SPT)Collaborators: David Fruman (SPT), Michael Lilly (SPT)
Oct. 2011
Proteomic ToolsScientific Highlights
Dr. Lan Huang, PhD: Mass Spectrometry1. New protein tagging strategies: tandem tags, in vivo biotinylation
2. Novel cross-linking chemistries: click-chemistry, novel spacers
3. Rapid Protein Complex IsolationProteasome network – collaboration with Dr. Peter Kaiser
Global Ubiquitination, Neddylation Network – collaboration with Dr. Peter KaiserRNA/Protein complexes (MS2-BioTRAP) – NCI IMAT R21CA133275
Tsai BP, Wang X, Huang L, Waterman ML.
2011. Mol Cell Proteomics.
“Quantitative Profiling of In Vivo-assembled RNA-Protein Complexes Using a Novel Integrated Proteomic Approach”
planned: NCI IMAT R33 Multi-PI RO1
CSB
SPT Discoveries:Moving Targets Closer to the Bedside
p53 Rescue A Functional Census of p53 Cancer and Suppressor MutantsDr. Peter Kaiser (SPT; PI) and Dr. Rick Lathrop (CSB; contact PI)
NCI R012010
Currently: in silico screen of >2,000,000 small molecules small molecule synthesis and test in cells
Scientific Highlights:
BiologyKaiser Lab, PI (SPT)Biological Chemistry
ChemistryChamberlin Lab (CSB)Pharmaceutical Sciences
Machine LearningLathrop Group, PI (CSB)Computer Science
Molecular BiologyHatfield Lab Computational BiologyResearch Laboratory
Molecular Dynamics
Amaro Group Pharmaceutical Sciences
Mouse GeneticsLee Lab (ABT)Biological Chemistry
Structural BiologyCocco Lab (NMR) (CSB)Luecke Lab (X-ray) (CSB)Molecular Biology and Biochemistry
Cancer Center - Value AddedNIH/NCI T32 #CA113265GHTF CoreCFCCC Seed grants
The p53 TeamScientific Highlights
The SPT ProgramChallenges• Size• Diversity of Discipline• Geographic Location (UCIMC, Main Campus, SOM)
Meeting the Challenges• Communication• Monitoring• Meetings• Goal: Linking Basic and Clinical groups
Disease Oriented TeamsJohn Krolewski (SPT): Prostate CancerRob Edwards (SPT)/Jason Zell (PPS): Colon
Cancer
Systems, Pathways and Targets ProgramCo-Leaders: Dr. John Lowengrub, Dr. Marian Waterman